Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New technology blocks gene to increase immune response against deadly brain tumor cells

26.05.2004


With new technology that uses short strands of genetic material to shut down a specific gene, researchers have regulated immune system proteins to boost production of cells that seek and destroy cancer cells. This approach may improve the effectiveness of vaccines in the treatment of tumors, including malignant brain tumors.



Results of the study appear in the June issue of the European Journal of Immunology, and the research was conducted at Cedars-Sinai’s Maxine Dunitz Neurosurgical Institute, where clinical trials of dendritic cell immunotherapy have been underway for several years.

Dendritic cells are the immune system’s most potent antigen-presenting cells – those that identify "foreign" substances for destruction. Because cancer cells often are not recognized by dendritic cells as antigens, the neurosurgeons and other scientists at the Institute have developed and studied a vaccine in the treatment of highly aggressive brain tumors called gliomas. They combine in the laboratory tumor cells that have been surgically removed and dendritic cells derived from a patient’s blood. The new cells are injected back into the patient to seek out other cancer cells for destruction.


Early clinical trials have shown an increase in survival rates among patients receiving the dendritic cell vaccine. Meanwhile, Institute researchers have been studying underlying genetic and cellular mechanisms as well as other methods for increasing immune response and enhancing the vaccine’s effectiveness.

"This study demonstrates that by turning off the interleukin 10 gene in the dendritic cell we can make a much more effective dendritic cell in terms of generating a significant immune response," said John S. Yu, MD, the article’s senior author and co-director of the Comprehensive Brain Tumor Program at Cedars-Sinai.

One of the functions of dendritic cells is to influence immature T cells to become either T helper type 1 (Th1) or T helper type 2 (Th2) cells. A naturally occurring protein, interleukin 12 (IL-12), interacting with dendritic cells, spurs the development of Th1 cells. Interleukin 10 (IL-10) inhibits the production of IL-12.

"Interleukin 10 is a molecule that generates a Th2 response, which is effective against organisms such as bacteria, but for a tumor treatment a Th1 response is our goal. The Th1 response is generated through T cells against a tumor," said Dr. Yu.

In this study, the researchers used a new approach called RNA interference to target the IL-10 gene, inserting short strands of synthetic IL-10 specific RNA (small interfering RNA or siRNA) into dendritic cells generated from peripheral blood cells. Suppression of the IL-10 gene inhibited the secretion of the IL-10 protein, which allowed increased production of IL-12. Naïve T cells co-cultured with siRNA-treated dendritic cells developed into Th1 cells and generated a strong immune response in lab studies.

Keith Black, MD, director of the Maxine Dunitz Neurosurgical Institute, the Division of Neurosurgery and the Comprehensive Brain Tumor Program, said this is one of several ongoing studies aimed at making the dendritic cell vaccine more effective against the deadliest tumors.

"We are accumulating evidence that brain tumors themselves play a role in suppressing the T cell response, and we think this is one reason gliomas grow so quickly. The strategy of shutting down the IL-10 gene may be one way of counteracting this immune inhibition," said Dr. Black, who holds the Ruth and Lawrence Harvey Chair in Neuroscience at Cedars-Sinai.



The study was supported in part by National Institutes of Health grant number NS02232 to Dr. Yu.

Cedars-Sinai is one of the largest nonprofit academic medical centers in the Western United States. For the fifth straight two-year period, it has been named Southern California’s gold standard in health care in an independent survey. Cedars-Sinai is internationally renowned for its diagnostic and treatment capabilities and its broad spectrum of programs and services, as well as breakthroughs in biomedical research and superlative medical education. It ranks among the top 10 non-university hospitals in the nation for its research activities.

Citation: European Journal of Immunology, June 2004: "Small interference RNA modulation of interleukin 10 in human monocyte-derived dendritic cells enhances the Th1 response."

Sandra Van | Van Communications
Further information:
http://www.csmc.edu/

More articles from Health and Medicine:

nachricht Correct connections are crucial
26.06.2017 | Charité - Universitätsmedizin Berlin

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Study shines light on brain cells that coordinate movement

26.06.2017 | Life Sciences

Smooth propagation of spin waves using gold

26.06.2017 | Physics and Astronomy

Switchable DNA mini-machines store information

26.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>